U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday.
The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The S&P 500 also fell, dropping, 0.62% to 4,287.95.
Australian Human Research Ethics Committee (HREC) grants approval for SAB to begin first-in-human Phase 1 clinical study of SAB-142, the first fully human anti-thymocyte immunoglobulin (ATG)SAB-142 directly targets
SAB Biotherapeutics (NASDAQ: SABS) has entered into a securities purchase agreement with certain investors to issue and sell shares of preferred stock in a private placement of up to $130 million in gross proceeds.
Gainers
Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.